Hepcidin antagonist-1
CAS No. 338965-09-6
Hepcidin antagonist-1( —— )
Catalog No. M35515 CAS No. 338965-09-6
Hepcidin antagonist-1 is an iron-modulating antagonist.Hepcidin antagonist-1 can be used to study metabolic disorders such as iron-deficiency diseases and anemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 535 | In Stock |
|
| 5MG | 487 | In Stock |
|
| 10MG | 730 | In Stock |
|
| 25MG | 1311 | In Stock |
|
| 50MG | 1795 | In Stock |
|
| 100MG | 2437 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHepcidin antagonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionHepcidin antagonist-1 is an iron-modulating antagonist.Hepcidin antagonist-1 can be used to study metabolic disorders such as iron-deficiency diseases and anemia.
-
DescriptionHepcidin antagonist-1 (example 104) is a potent hepcidin (hepcidine) antagonist with an IC50<50 μM. Hepcidin antagonist-1 can be used for researching iron metabolism disorders, such as anemias.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number338965-09-6
-
Formula Weight346.21
-
Molecular FormulaC16H13Cl2N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=NC(=NC(N)=C1CC1=C(Cl)C=C(Cl)C=C1)C1=NC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Franz DüRRENBERGER, et al. Novel pyrimidine and triazine hepcidine antagonists. WO2011026835
molnova catalog
related products
-
Alpinetin
Alpinetin has antibacterial activity.Alpinetin has anti-inflammatory activity.
-
Broflanilide
Broflanilide is metabolized to desmethyl-broflanilide, which is a potent antagonist at the insect resistant-to-dieldrin GABA receptor and inhibits S. litura RDL GABAR with IC50 of 1.3 nM.
-
FB23
FB23 directly binds to FTO and selectively inhibits FTO's m6A demethylase activity. (FTO, an mRNA N6-methyladenosine (m6A) demethylase, was reported to promote leukemogenesis.)
Cart
sales@molnova.com